SCHEMBL18397764

SCHEMBL18397764

NC(=O)OCc1cc(=O)c2cc(-c3cnc4ccccc4c3)ccc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.43
▸ WDR77 Q9BQA1 1/20 0.43
▸ MTOR P42345 5/20 0.41
▸ PIK3CD O00329 5/20 0.41
▸ PIK3CA P42336 4/20 0.41
▸ PIK3CB P42338 2/20 0.41
▸ PIK3CG P48736 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40
▸ CSNK1G2 P78368 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ MAP4K5 Q9Y4K4 1/20 0.40
▸ LOXL2 Q9Y4K0 2/20 0.39
▸ GRM4 Q14833 1/20 0.39
▸ CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18397771 0.84 PRMT5 (0.54) PRMT5WDR77MTORPIK3CDPIK3CA
Hydrochloric Acid SCHEMBL18397758 0.83 PRMT5 (0.53) PRMT5WDR77MTORPIK3CDPIK3CA
SCHEMBL20438079 0.78 BCHE (0.43) PRMT5WDR77MTORPIK3CDPIK3CA
SCHEMBL18397876 0.76 PIM1 (0.48) PRMT5WDR77MKNK2LOXL2
SCHEMBL1976012 0.75 KDM4E (0.53) KDM4ENPC1MAPTRAB9ALOXL2
SCHEMBL18397952 0.72 LOXL2 (0.49) NPC1LOXL2
SCHEMBL22969819 0.70 CASP3 (0.55) PRMT5WDR77MTORPIK3CDPIK3CA
SCHEMBL14350755 0.69 PIM1 (0.61) MKNK2
SCHEMBL14075590 0.69 MGAM (0.47) KDM4ERAB9A
SCHEMBL7431675 0.69 AGXT (0.63) KDM4ENPC1ALDH1A1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180215727-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. 2018-08-02 — — US disclosed
EP-3325462-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF Pharmakea, Inc. (US) 2018-05-30 — — EP disclosed
WO-2017015221-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2017-01-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180215727-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF LOXL2, LOXL1, LOX PRMT5 2827/4885WDR77 2155/4885MTOR 4716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback